Left Atrial Appendage Closure

0

Pipeline Programs↗

4

Active Trials↗

0

Companies Involved↗

Left Atrial Appendage Closure is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Recruiting3 · 38%

Unknown status3 · 38%

Completed1 · 13%

Active, not recruiting1 · 13%

Clinical Trials

Trial Activity

8 trials

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure

Recruiting·National Institute of Cardiology, Warsaw, Poland·Phase 4·NCT03445949·200 enrolled

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients

Recruiting·National Institute of Cardiology, Warsaw, Poland·Phase 4·NCT05660811·80 enrolled

Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure

Recruiting·OOCEAN-SHD Study Group·Phase 4·NCT07125417·500 enrolled

Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Active, not recruiting·CCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec·Phase 4·NCT03568890·510 enrolled

Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation

Completed·BBoston Scientific Corporation·N/A·NCT03795298·1,600 enrolled

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study

Unknown status·AAzienda Ospedaliero Universitaria Maggiore della Carita·Phase 3·NCT05554822·574 enrolled

Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI

Unknown status·MMeshalkin Research Institute of Pathology of Circulation·Phase 2·NCT02492230·50 enrolled

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

Unknown status·UUniversity Hospital, Bordeaux·Phase 4·NCT04796714·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)